Short Interest in Nukkleus Inc. (NASDAQ:DFNS) Declines By 97.9%

Nukkleus Inc. (NASDAQ:DFNSGet Free Report) saw a large decline in short interest in the month of July. As of July 31st, there was short interest totaling 279,125 shares, a decline of 97.9% from the July 15th total of 13,439,238 shares. Based on an average daily volume of 14,067,878 shares, the days-to-cover ratio is presently 0.0 days. Currently, 41.4% of the shares of the company are sold short.

Analyst Upgrades and Downgrades

Several equities analysts recently issued reports on the company. Noble Financial upgraded Nukkleus to a “strong-buy” rating in a research note on Monday, June 29th. Weiss Ratings lowered Nukkleus from a “sell (d+)” rating to a “sell (e+)” rating in a report on Monday, July 20th. Finally, Wall Street Zen upgraded Nukkleus to a “sell” rating in a research report on Saturday, July 25th. One analyst has rated the stock with a Strong Buy rating and one has issued a Sell rating to the company’s stock. According to MarketBeat, the company has an average rating of “Moderate Buy”.

Read Our Latest Stock Report on Nukkleus

Institutional Inflows and Outflows

Institutional investors have recently modified their holdings of the company. Geode Capital Management LLC boosted its holdings in shares of Nukkleus by 193.7% in the 4th quarter. Geode Capital Management LLC now owns 124,714 shares of the company’s stock worth $503,000 after acquiring an additional 82,252 shares in the last quarter. UBS Group AG boosted its stake in Nukkleus by 23.3% in the third quarter. UBS Group AG now owns 80,512 shares of the company’s stock worth $564,000 after purchasing an additional 15,223 shares in the last quarter. LPL Financial LLC bought a new stake in shares of Nukkleus during the fourth quarter worth $120,000. Engineers Gate Manager LP bought a new stake in shares of Nukkleus during the fourth quarter worth $96,000. Finally, State Street Corp increased its stake in shares of Nukkleus by 70.7% in the fourth quarter. State Street Corp now owns 17,863 shares of the company’s stock valued at $72,000 after buying an additional 7,400 shares in the last quarter. Institutional investors own 12.47% of the company’s stock.

Nukkleus Price Performance

DFNS stock traded up $1.03 during trading on Wednesday, hitting $37.61. The company had a trading volume of 271,973 shares, compared to its average volume of 1,333,982. The company has a fifty day moving average price of $26.06 and a two-hundred day moving average price of $105.46. Nukkleus has a fifty-two week low of $3.70 and a fifty-two week high of $1,948.75. The company has a market cap of $28.58 million, a P/E ratio of -0.10 and a beta of -5.80. The company has a current ratio of 0.25, a quick ratio of 0.21 and a debt-to-equity ratio of 0.07.

Nukkleus (NASDAQ:DFNSGet Free Report) last released its quarterly earnings data on Wednesday, May 20th. The company reported ($142.50) earnings per share (EPS) for the quarter. The business had revenue of $3.65 million during the quarter. Equities research analysts expect that Nukkleus will post -4.21 earnings per share for the current fiscal year.

Nukkleus Company Profile

(Get Free Report)

Nukkleus Inc, a financial technology company, provides blockchain-enabled technology solutions worldwide. It focuses on providing software and technology solutions for retail foreign exchange trading industry. The company provides transactions platform for dealing and risk management services. It also offers cross-border payment and transactions solutions and blockchain-enabled financial services solutions to institutional investors. In addition, the company provides software, technology, customer sales and marketing, and risk management technology hardware and software solutions.

Further Reading

Receive News & Ratings for Nukkleus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nukkleus and related companies with MarketBeat.com's FREE daily email newsletter.